Serum tetranectin as a preoperative indicator for postoperative complications in Danish ovarian cancer patients

Gynecologic Oncology

Volumn 117, Issue 3, 2010, Pages 446-450

  Begum, Farah Diba ^a   Høgdall, Estrid ^b,c   Christensen, Ib Jarle ^d   Christensen, Lise ^e   Kjaer, Susanne Krüger ^a,b   Blaakaer, Jan ^f   Petri, Anette Lykke ^a   Høgdall, Claus ^a  

^a International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health   (Denmark)

^b DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^c GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^d FINSEN LABORATORY   (Denmark)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

^f AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Alcohol; Postoperative complications; Smoking; Tetranectin

Indexed keywords

TETRANECTIN;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BLOOD SAMPLING; CANCER STAGING; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; FEMALE; GASTROENTERITIS; HEMATOMA; HISTOLOGY; HUMAN; HUMAN TISSUE; INFECTION; LUNG DISEASE; MAJOR CLINICAL STUDY; NEUROLOGIC DISEASE; OVARY CANCER; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SMOKING HABIT; STOMACH ULCER; THROMBOEMBOLISM; WOUND DEHISCENCE;

ADULT; AGED; ALCOHOL DRINKING; DENMARK; FEMALE; HUMANS; LECTINS, C-TYPE; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; SMOKING; TUMOR MARKERS, BIOLOGICAL;

EID: 77951978187     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2010.02.023     Document Type: Article

References (31)

1. Dansk Gynækologisk Cancer Database, Årsrapport 2006-2007. ISSN: 1902-7877.
2. NORDCAN, Version 3.4. Available at http://www-dep.iarc.fr/nordcan.htm. Accessed on 14th May 2009.
3. Qazi F., and McGuire W.P. The treatment of epithelial ovarian cancer. CA Cancer J Clin 45 (1995) 88-101
4. Bjorge T., Engeland A., Sundfor K., and Trope C.G. Prognosis of 2,800 patients with epithelial ovarian cancer diagnosed during 1975-94 and treated at the Norwegian Radium Hospital. Acta Obstet Gynecol Scand 77 (1998) 777-781
5. Aletti G.D., Dowdy S.C., Podrats K.C., and Cliby W.A. Analysis of factors impacting operability in stage IV ovarian cancer: rationale use of a triage system. Gynecol Oncol 105 (2007) 84-89
6. Pomel C., Barton D.P., McNeish I., and Shepherd J. A statement for extensive primary cytoreductive surgery in advanced ovarian cancer. BJOG 115 (2008) 808-810
7. Venesmaa P., and Ylikorkala O. Morbidity and mortality associated with primary and repeat operations for ovarian cancer. Obstet Gynecol 79 (1992) 168-172
8. Møller A.M., Villebro N., Pedersen T., and Tønnesen H. Effect of preoperative smoking intervention on postoperative complications: a randomised clinical trial. Lancet 359 (2002) 114-117
9. Clemmensen I., Petersen L., and Kluft C. Purification and characterization of a novel oligomeric, plasminogen kringle 4 binding protein from human plasma: tetranectin. Eur J Biochem 156 (1986) 327-333
10. Mellbring G., Dahlgren S., Wiman B., and Sunnegaardh O. Relationship between preoperative status of the fibrinolytic system and occurrence of deep vein thrombosis after major abdominal surgery. Thromb Res 39 (1985) 157-163
11. Jørgensen L.N., Lind B., Hauch O., Leffers A., Albrecht-Beste E., and Konradsen A.G. Thrombin-antithrombin III-complex and fibrin degradation products in plasma: surgery and postoperative deep venous thrombosis. Thromb Res 59 (1990) 69-76
12. Aranda A., Paramo J.A., and Rocha E. Fibrinolytic activity in plasma after gynecological and urological surgery. Haemostasis 18 (1988) 129-134
13. Bergmann S., and Hammerschmidt S. Fibrinolysis and host response in bacterial infections. Thromb Haemost 98 (2007) 512-520
14. Südhoff T., and Schneider W. Fibrinolytic mechanisms in tumor growth and spreading. Clin Invest 70 (1992) 631-636
15. Høgdall C.K., Høgdall E.V., Jørgensen L.N., and Clemmensen I. Changes in plasma tetranectin following hip surgery with or without thrombotic complications. Thromb Res 67 (1992) 399-405
16. Glud E., Kjaer S.K., Thomsen B.L., et al. Hormone therapy and the impact of estrogen intake on the risk of ovarian cancer. Arch Intern Med 164 (2004) 2253-2259
17. Recommendations from The National Board of Health http://sst.dk/Sundhed%20og%20forebyggelse/Alkohol/Anbefalinger.aspx (accessed 19. may 2009).
18. Høgdall C.K., Høgdall E.V., Hørding U., et al. Plasma tetranectin and ovarian neoplasms. Gynecol Oncol 43 (1991) 103-107
19. Clemmensen I., Lund L.R., Christensen L., and Andreasen P.A. A tetranectin-related protein is produced and deposited in extracellular matrix by human embryonal fibroblasts. Eur J Biochem 195 (1991) 735-741
20. Høgdall C.K., Christensen L., and Clemmensen I. The prognostic value of tetranectin immunoreactivity and plasma tetranectin in patients with ovarian cancer. Cancer 72 (1993) 2415-2422
21. Iozzo R.V., Bolender R.P., and Wight T.N. Proteoglycan changes in the intercellular matrix of human colon carcinoma: an integrated biochemical and sterologic analysis. Lab Invest 47 (1982) 124-138
22. Clemmensen I. Interaction of tetranectin with sulphated polysaccharides and trypan. Scand J Clin Lab Invest 49 (1989) 719-725
23. Kluft C., Los P., and Clemmensen I. Calcium-dependent binding of tetranectin to fibrin. Thromb Res 55 (1989) 233-238
24. Doll R., Peto R., Boreham J., and Sutherland I. Mortality in relation to smoking: 50 years' observations on male British doctors. BMJ 328 (2004) 1519
25. Strandberg A.Y., Strandberg T.E., Pitkala K., Salomaa V.V., Tilvis R.S., and Miettinen T.A. The effect of smoking in midlife on health-related quality of life in old age: a 26-year prospective study. Arch Intern Med 168 (2008) 1968-1974
26. Sorensen L.T., Jørgensen T., Kirkeby L.T., Skovdal J., Vennits B., and Wille-Jørgensen P. Smoking and alcohol abuse are major risk factors for anastomotic leakage in colorectal surgery. Br J Surg 86 (1999) 927-931
27. Begum F.D., Høgdall C.K., Kjaer S.K., et al. The prognostic value of plasma soluble urokinase plasminogen activator receptor (suPAR) levels in stage III ovarian cancer patients. Anticancer Res 24 (2004) 1981-1985
28. Doll R., Peto R., Boreham J., and Sutherland I. Mortality in relation to smoking: 50 years' observations on male British doctors. BMJ 328 (2004) 1519
29. Strandberg A.Y., Strandberg T.E., Pitkala K., Salomaa V.V., Tilvis R.S., and Miettinen T.A. The effect of smoking in midlife on health-related quality of life in old age: a 26-year prospective study. Arch Intern Med 168 (2008) 1968-1974
30. Sorensen L.T., Jørgensen T., Kirkeby L.T., Skovdal J., Vennits B., and Wille-Jørgensen P. Smoking and alcohol abuse are major risk factors for anastomotic leakage in colorectal surgery. Br J Surg 86 (1999) 927-931
31. Vergote I, Trope CG, Amant F, et al. EORTC-GCG/NCIC-CTG randomised trial comparing primary debulking surgery with neoadjuvant chemotherapy in stage IIIC-IV ovarian, fallopian tube and peritoneal cancer (OVCA). Abstract available online. Accessed on 14 May 2009.